Neuro65/AOCN2024

Presentation information

Print

Neuroscience Frontier Symposium

English

[NFS-04] Neuroscience Frontier Symposium 04「A new era of cell and gene therapy for neurological diseases」

Fri. May 31, 2024 3:00 PM - 5:00 PM Room1 (Hall C, C Block, 4F, TIF)

Chair(s): Hideyuki Okano (Keio University, Japan), Haruhisa Inoue (Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)

[NFS-04-3] Mesenchymal stem cell therapy for Spinocerebellar degeneration

Chikafumi Yokoyama (REPROCELL Inc., Japan)

photo
Dr. Yokoyama joined REPROCELL Inc. in 2004 as a general manager of business development, a year after the formation of the company. Since 2005 he has been the Chief Executive Officer during which time he raised investment funds, arranged the initial public offering, and managed several global corporate acquisitions. Prior to REPROCELL, Dr. Yokoyama worked as a Project Leader for a new business development in 3M Japan. And earlier, he was employed in McKinsey and Company Inc. as a management consultant. Dr. Yokoyama received his Ph.D. in chemistry from Tokyo University in 1996.

Abstract password authentication.
You can find the password on page 15 of the program book.

Password